Daniela Varges

3.0k total citations
41 papers, 1.3k citations indexed

About

Daniela Varges is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Daniela Varges has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 19 papers in Neurology and 18 papers in Neurology. Recurrent topics in Daniela Varges's work include Prion Diseases and Protein Misfolding (28 papers), Neurological diseases and metabolism (16 papers) and Parkinson's Disease Mechanisms and Treatments (9 papers). Daniela Varges is often cited by papers focused on Prion Diseases and Protein Misfolding (28 papers), Neurological diseases and metabolism (16 papers) and Parkinson's Disease Mechanisms and Treatments (9 papers). Daniela Varges collaborates with scholars based in Germany, Spain and Slovakia. Daniela Varges's co-authors include Inga Zerr, Matthias Schmitz, Uta Heinemann, Anna Krasnianski, Walter Schulz‐Schaeffer, Bettina Meißner, Franc Llorens, Kai Kallenberg, Maria Cramm and André Karch and has published in prestigious journals such as Nature Communications, Brain and Neurology.

In The Last Decade

Daniela Varges

41 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Varges Germany 21 988 561 463 296 183 41 1.3k
Anna Krasnianski Germany 18 904 0.9× 448 0.8× 348 0.8× 171 0.6× 161 0.9× 34 1.1k
Alison J. E. Green United Kingdom 16 793 0.8× 435 0.8× 890 1.9× 396 1.3× 143 0.8× 24 1.6k
K. Jendroska Germany 14 688 0.7× 545 1.0× 165 0.4× 325 1.1× 82 0.4× 22 1.2k
Angela Mammana Italy 17 387 0.4× 316 0.6× 872 1.9× 493 1.7× 304 1.7× 34 1.4k
Oren S. Cohen Israel 16 289 0.3× 169 0.3× 257 0.6× 66 0.2× 142 0.8× 38 571
Adolfo Jiménez‐Huete Spain 13 238 0.2× 142 0.3× 134 0.3× 143 0.5× 209 1.1× 42 612
David J. Braun United States 15 205 0.2× 223 0.4× 136 0.3× 163 0.6× 40 0.2× 22 837
Ryotaro Ishii Japan 14 200 0.2× 161 0.3× 428 0.9× 300 1.0× 204 1.1× 36 912
Haeng Jun Kim South Korea 9 568 0.6× 171 0.3× 61 0.1× 338 1.1× 29 0.2× 12 863
Huicong Kang China 14 188 0.2× 98 0.2× 417 0.9× 87 0.3× 125 0.7× 43 828

Countries citing papers authored by Daniela Varges

Since Specialization
Citations

This map shows the geographic impact of Daniela Varges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Varges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Varges more than expected).

Fields of papers citing papers by Daniela Varges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Varges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Varges. The network helps show where Daniela Varges may publish in the future.

Co-authorship network of co-authors of Daniela Varges

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Varges. A scholar is included among the top collaborators of Daniela Varges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Varges. Daniela Varges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmitz, Matthias, Juan Carlos Espinosa, Natalia Fernández‐Borges, et al.. (2022). Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease. Molecular Neurobiology. 59(9). 1–9. 8 indexed citations
2.
Hermann, Péter, Daniela Varges, Stefan Goebel, et al.. (2022). Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline. Diagnostics. 12(5). 1259–1259. 1 indexed citations
3.
Schmitz, Matthias, Anna Villar‐Piqué, Fabian Maass, et al.. (2021). Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies. Frontiers in Aging Neuroscience. 13. 717930–717930. 20 indexed citations
4.
Villar‐Piqué, Anna, Matthias Schmitz, Péter Hermann, et al.. (2019). Plasma YKL-40 in the spectrum of neurodegenerative dementia. Journal of Neuroinflammation. 16(1). 145–145. 51 indexed citations
5.
Schmitz, Matthias, Anna Villar‐Piqué, Franc Llorens, et al.. (2018). Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy. Molecular Neurobiology. 56(5). 3476–3483. 23 indexed citations
6.
Gmitterová, Karin, Joanna Gawinecka, Franc Llorens, et al.. (2018). Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson’s disease dementia. European Archives of Psychiatry and Clinical Neuroscience. 270(4). 461–470. 20 indexed citations
7.
Llorens, Franc, Matthias Schmitz, Daniela Varges, et al.. (2016). Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies. Journal of Neurology. 263(11). 2271–2277. 35 indexed citations
8.
Schmitz, Matthias, Maria Cramm, Franc Llorens, et al.. (2016). Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie. Scientific Reports. 6(1). 28711–28711. 27 indexed citations
9.
Llorens, Franc, Matthias Schmitz, Péter Hermann, et al.. (2015). Increased albumin CSF/serum ratio in dementia with Lewy bodies. Journal of the Neurological Sciences. 358(1-2). 398–403. 23 indexed citations
10.
Krasnianski, Anna, Uta Heinemann, Claudia Ponto, et al.. (2015). Clinical findings and diagnosis in genetic prion diseases in Germany. European Journal of Epidemiology. 31(2). 187–196. 23 indexed citations
11.
Varges, Daniela, Walter Schulz‐Schaeffer, Wiebke M. Wemheuer, et al.. (2013). Spongiform encephalopathy in siblings with no evidence of protease-resistant prion protein or a mutation in the prion protein gene. Journal of Neurology. 260(7). 1871–1879. 1 indexed citations
12.
Krasnianski, Anna, Pascual Sánchez‐Juan, Michael Bartl, et al.. (2013). A proposal of new diagnostic pathway for fatal familial insomnia. Journal of Neurology Neurosurgery & Psychiatry. 85(6). 654–659. 34 indexed citations
13.
Schmitz, Matthias, Badrul Hasan, Michael Beekes, et al.. (2010). Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt–Jakob disease. European Journal of Neuroscience. 31(11). 2024–2031. 17 indexed citations
14.
Gmitterová, Karin, Uta Heinemann, Joanna Gawinecka, et al.. (2009). 8-OHdG in Cerebrospinal Fluid as a Marker of Oxidative Stress in Various Neurodegenerative Diseases. Neurodegenerative Diseases. 6(5-6). 263–269. 67 indexed citations
15.
Mollenhauer, Brit, Uta Heinemann, Daniela Varges, et al.. (2008). Movement disturbances in the differential diagnosis of Creutzfeldt‐Jakob disease. Movement Disorders. 24(3). 350–356. 16 indexed citations
16.
Krasnianski, Anna, Kai Kallenberg, Donald A. Collie, et al.. (2008). MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter‐observer agreement study. European Journal of Neurology. 15(8). 762–771. 14 indexed citations
17.
Krasnianski, Anna, Uta Heinemann, Bettina Meißner, et al.. (2008). Fatal familial insomnia: Clinical features and early identification. Annals of Neurology. 63(5). 658–661. 46 indexed citations
18.
Krasnianski, Anna, Bettina Meißner, Walter Schulz‐Schaeffer, et al.. (2006). Clinical Features and Diagnosis of the MM2 Cortical Subtype of Sporadic Creutzfeldt-Jakob Disease. Archives of Neurology. 63(6). 876–876. 61 indexed citations
19.
Schulz‐Schaeffer, Walter, Monika Bodemer, Barbara Ciesielczyk, et al.. (2006). Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD?. BMC Neurology. 6(1). 35–35. 20 indexed citations
20.
Schulz‐Schaeffer, Walter, Bettina Meißner, Kai Kallenberg, et al.. (2005). Clinical course in young patients with sporadic Creutzfeldt–Jakob disease. Annals of Neurology. 58(4). 533–543. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Krasnianski Breakdown of academic impact, for papers by Alison J. E. Green Breakdown of academic impact, for papers by K. Jendroska Breakdown of academic impact, for papers by Angela Mammana Breakdown of academic impact, for papers by Oren S. Cohen Breakdown of academic impact, for papers by Adolfo Jiménez‐Huete Breakdown of academic impact, for papers by David J. Braun Breakdown of academic impact, for papers by Ryotaro Ishii Breakdown of academic impact, for papers by Haeng Jun Kim Breakdown of academic impact, for papers by Huicong Kang
Rankless by CCL
2026